Yesterday, June 2, 2016, 99 U.S. common stocks issued filings of shares being bought or sold by insiders. The transactions ranged in value from $41.74 to $25,050,000.00.

Highlighted Stocks Traded by Insiders:

Inteliquent (IQNT) - FREE Research Report

Schoder John M, who is EVP & Chief Marketing Officer at Inteliquent, sold 2,315 shares at $17.10 on June 2, 2016. Following this transaction, the EVP & Chief Marketing Officer owned 48,172 shares meaning that the stake was reduced by 4.59% with the 2,315-share transaction.

The shares most recently traded at $17.82, up $0.72, or 4.04% since the insider transaction. Historical insider transactions for Inteliquent go as follows:

  • 4-Week # shares bought: 20,000
  • 4-Week # shares sold: 5,000
  • 12-Week # shares bought: 20,000
  • 12-Week # shares sold: 6,000
  • 24-Week # shares bought: 20,000
  • 24-Week # shares sold: 37,413

The average volume for Inteliquent has been 245,800 shares per day over the past 30 days. Inteliquent has a market cap of $566.4 million and is part of the technology sector and telecommunications industry. Shares are up 0.56% year-to-date as of the close of trading on Thursday.

Inteliquent, Inc. provides voice telecommunications services on a wholesale basis in the United States and internationally. The company offers its services using an all-IP network, which enables to deliver global connectivity for various media, including voice. The stock currently has a dividend yield of 3.85%. The company has a P/E ratio of 15.5. Currently, there are 2 analysts who rate Inteliquent a buy, no analysts rate it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on IQNT - FREE

TheStreet Quant Ratings

rates Inteliquent as a

buy

. The company's strengths can be seen in multiple areas, such as its robust revenue growth and largely solid financial position with reasonable debt levels by most measures. We feel its strengths outweigh the fact that the company has had lackluster performance in the stock itself. Get the full

Inteliquent Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

Medidata Solutions (MDSO) - FREE Research Report

Taylor Robert, who is Director at Medidata Solutions, sold 3,752 shares at $45.03 on June 2, 2016. Following this transaction, the Director owned 50,742 shares meaning that the stake was reduced by 6.89% with the 3,752-share transaction.

The shares most recently traded at $45.11, up $0.08, or 0.18% since the insider transaction. Historical insider transactions for Medidata Solutions go as follows:

  • 4-Week # shares bought: 1,500
  • 4-Week # shares sold: 29,417
  • 12-Week # shares bought: 1,500
  • 12-Week # shares sold: 133,134
  • 24-Week # shares bought: 1,500
  • 24-Week # shares sold: 133,134

The average volume for Medidata Solutions has been 361,900 shares per day over the past 30 days. Medidata Solutions has a market cap of $2.6 billion and is part of the technology sector and computer software & services industry. Shares are down 5.74% year-to-date as of the close of trading on Thursday.

Medidata Solutions, Inc. provides cloud-based solutions for life sciences worldwide. The company offers applications and data analytics for clinical development. The company has a P/E ratio of 138.6. Currently, there are 8 analysts who rate Medidata Solutions a buy, 1 analyst rates it a sell, and 2 rate it a hold.

Exclusive Offer: Get the latest Stock Analysis on MDSO - FREE

TheStreet Quant Ratings

rates Medidata Solutions as a

hold

. The company's strengths can be seen in multiple areas, such as its revenue growth, compelling growth in net income and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including premium valuation, weak operating cash flow and a generally disappointing performance in the stock itself. Get the full

Medidata Solutions Ratings Report

from

TheStreet Quant Ratings

now.

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.

xG Technology (XGTI) - FREE Research Report

Woodyatt Ross James, who is President at xG Technology, sold 44,500 shares at $0.18 on June 2, 2016. Following this transaction, the President owned 5,624 shares meaning that the stake was reduced by 88.78% with the 44,500-share transaction.

The shares most recently traded at $3.53, up $3.35, or 94.9% since the insider transaction. Historical insider transactions for xG Technology go as follows:

  • 4-Week # shares sold: 12,000
  • 12-Week # shares bought: 245,984
  • 12-Week # shares sold: 12,000
  • 24-Week # shares bought: 245,984
  • 24-Week # shares sold: 12,000

The average volume for xG Technology has been 874,700 shares per day over the past 30 days. xG Technology has a market cap of $68.0 million and is part of the technology sector and telecommunications industry.

xG Technology, Inc. engages in the development of communication technologies for wireless networks worldwide.

Exclusive Offer: Get the latest Stock Analysis on XGTI - FREE

EXCLUSIVE OFFER: See inside Jim Cramer's multi-million dollar charitable trust portfolio to see the stocks he thinks could be potential winners. Click here to see his holdings for 14-days FREE.